2021
Race, Ethnicity and Geographical Variables in the Study of Polycystic Ovarian Syndrome
Hussain Z, Stone T, Stachenfeld N. Race, Ethnicity and Geographical Variables in the Study of Polycystic Ovarian Syndrome. The FASEB Journal 2021, 35 DOI: 10.1096/fasebj.2021.35.s1.02899.Peer-Reviewed Original ResearchPolycystic ovarian syndromeRandomized control trialOvarian syndromePolycystic ovariesClinical trialsManagement of PCOSCardiovascular disease factorsOligomenorrhea/amenorrheaPCOS diagnostic criteriaPolycystic ovarian diseaseCommon endocrine disorderSigns/symptomsSymptoms/signsNon-Hispanic ethnicityPCO patientsAndrogen excessMenstrual disturbancesMetabolic syndromeEndocrine disordersEthnicity informationOvarian diseasePCOS participantsPCOS studyTotal subjectsControl trial
2019
Effects of bazedoxifene/conjugated estrogens on reproductive endocrinology and reproductive tract ultrasonographic appearance in premenopausal women: a preliminary study
Flores VA, Leone C, Taylor HS, Stachenfeld NS. Effects of bazedoxifene/conjugated estrogens on reproductive endocrinology and reproductive tract ultrasonographic appearance in premenopausal women: a preliminary study. Gynecological Endocrinology 2019, 35: 390-394. PMID: 30668182, DOI: 10.1080/09513590.2018.1559288.Peer-Reviewed Original ResearchConceptsBZA/CEPremenopausal womenConjugated estrogensReproductive hormonesUltrasonographic appearanceBazedoxifene/conjugated estrogensAbnormal ovarian folliculogenesisReproductive hormone changesCase series studyUnited States FoodEstrogen-receptor complexEndometrial alterationsDaily administrationSerum assessmentLH surgeMenopausal womenMenopausal symptomsMenstrual cycleClinical trialsEndocrinologic functionsOvarian morphologyHormone levelsPosttreatment valuesMurine modelOvarian folliculogenesis
2017
A translational approach for NMDA receptor profiling as a vulnerability biomarker for depression and schizophrenia
Gunduz‐Bruce H, Kenney J, Changlani S, Peixoto A, Gueorguieva R, Leone C, Stachenfeld N. A translational approach for NMDA receptor profiling as a vulnerability biomarker for depression and schizophrenia. Quarterly Journal Of Experimental Physiology And Cognate Medical Sciences 2017, 102: 587-597. PMID: 28294453, DOI: 10.1113/ep086212.Peer-Reviewed Original ResearchConceptsSubgroup of patientsHealthy control subjectsNMDA receptorsControl subjectsDepressed patientsAVP releaseAnimal studiesSchizophrenic subjectsTranslational approachVivo evidenceRecent clinical trialsNMDA receptor functionPlasma arginine vasopressin concentrationNMDA receptor activityHypertonic saline infusionNMDA antagonist ketamineArginine vasopressin concentrationHypertonic salineInverse associationClinical trialsHealthy controlsSaline infusionGlutamate signalingSchizophrenic patientsVasopressin concentration